Lu Pengqi, Deputy Director of the National Intellectual Property Administration, met with the Chairman of the Board of Roche Group from Switzerland

Recently, Lu Pengqi, Deputy Director of the China National Intellectual Property Administration, met with a visiting delegation led by Severin Schwan, Chairman of the Board of Roche Group, in Beijing. Lu Pengqi stated that in recent years, intellectual property protection has increasingly attracted the attention of both domestic and foreign enterprises as an important aspect of the business environment. The China National Intellectual Property Administration has always adhered to equal protection of intellectual property rights for both domestic and foreign-funded enterprises, effectively safeguarding the legitimate rights and interests of foreign investors. In the future, the China National Intellectual Property Administration will continue to maintain a proactive and open attitude, keeping good communication with rights holders and stakeholders from various countries. Schwan expressed that intellectual property is the core competitiveness for the survival and development of innovative pharmaceutical companies. Supported by China's continuously improving intellectual property protection system, more and more multinational pharmaceutical companies are confident in the Chinese market and are deepening their localization strategies. Roche Group will continue to expand its R&D investment in China and actively promote the benefits of pharmaceutical innovations originating from China to the world